GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Total Liabilities

Quantum Genomics (Quantum Genomics) Total Liabilities : $21.20 Mil (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Total Liabilities?

Quantum Genomics's Total Liabilities for the quarter that ended in Dec. 2022 was $21.20 Mil.

Quantum Genomics's quarterly Total Liabilities declined from Dec. 2021 ($12.43 Mil) to Jun. 2022 ($12.39 Mil) but then increased from Jun. 2022 ($12.39 Mil) to Dec. 2022 ($21.20 Mil).

Quantum Genomics's annual Total Liabilities increased from Dec. 2020 ($8.63 Mil) to Dec. 2021 ($12.43 Mil) and increased from Dec. 2021 ($12.43 Mil) to Dec. 2022 ($21.20 Mil).


Quantum Genomics Total Liabilities Historical Data

The historical data trend for Quantum Genomics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Total Liabilities Chart

Quantum Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.35 4.71 8.63 12.43 21.20

Quantum Genomics Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.63 12.45 12.43 12.39 21.20

Quantum Genomics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Quantum Genomics's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17.971+(3.214+0.011999999999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=21.20

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=25.061-3.864
=21.20

Quantum Genomics's Total Liabilities for the quarter that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17.971+(3.214+0.011999999999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=21.20

Total Liabilities=Total Assets (Q: Dec. 2022 )-Total Equity (Q: Dec. 2022 )
=25.061-3.864
=21.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quantum Genomics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum Genomics (Quantum Genomics) Business Description

Traded in Other Exchanges
Address
33, Rue Marbeuf, Paris, FRA, 75008
Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (Quantum Genomics) Headlines

From GuruFocus

Quantum Genomics Signs a Strategic Contract with Delpharm

By Marketwired Marketwired 12-16-2020

Quantum Genomics Announces Granting of New Patents Protecting QGC606

By GuruFocusNews GuruFocusNews 03-28-2022

Quantum Genomics Raises a Gross Amount of Approximately � 15 M

By GuruFocusNews GuruFocusNews 04-26-2022